Literature DB >> 11952056

Acute mountain sickness in Jade Mountain climbers of Taiwan.

Wei-Fong Kao1, Chien-Chun Kuo, Teh-Fu Hsu, Hsing Chang, Ying-Ying Sung, David H T Yen, Jer-Kan Wu, Chen-Hsen Lee.   

Abstract

BACKGROUND: Although there are more than 200 peaks higher than 3000 m in the Taiwan Alps, no data on the incidence of acute mountain sickness (AMS) are available. This study investigated the incidence of AMS in Jade Mountain climbers.
METHODS: The study was performed at the entrance of Jade Mountain, the highest peak (3952 m) in Taiwan. A standardized form was used to collect information. All the recorders had previously been trained in the management of high altitude illness. The Lake Louise consensus was used for the diagnosis of AMS.
RESULTS: There were 93 trekkers (18 females and 71 males) who were surveyed. Four records with incomplete data were excluded, leaving 89 records for analysis. The ages ranged from 20-68 yr, with an average age of 41.1 +/- 11.2 SD. All subjects had a home residence below 1 km. The most common high altitude symptoms were headaches. Some 25 trekkers (28%) [corrected] met the diagnoses of AMS. The most common site of the AMS cases feeling their worst symptoms was in the midway overnight hut, and not on the summit. The lower the O2 saturation recorded at the entrance (2659 m) of Jade Mountain, the higher the score of the Lake Louise Acute Mountain Sickness Score (LLAMSS).
CONCLUSIONS: Acute mountain sickness is a common problem in Taiwan summit climbers. In our study, 28% [corrected] of the Jade Mountain trekkers met the diagnosis of AMS; however, the incidence of AMS was lower than that of other studies at similar altitudes.

Entities:  

Mesh:

Year:  2002        PMID: 11952056

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  5 in total

Review 1.  Altitude sickness.

Authors:  David Murdoch
Journal:  BMJ Clin Evid       Date:  2010-03-18

2.  Three-Minute Step Test for Predicting Acute Mountain Sickness: A Post Hoc Analysis of Rhodiola Crenulata Extract for Prevention of Acute Mountain Sickness, a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.

Authors:  Hsiang Yun Lo; Lisa Li-Chuan Chen; Deng-Huang Su; Chung-Hsien Chen; Tai-Yi Hsu; Shih-Hao Wang; Yi-Ming Weng; Cheng-Wei Chan; Shih-Hao Wu; Hang-Cheng Chen; Te-Fa Chiu
Journal:  J Acute Med       Date:  2018-03-01

3.  Incidence and Determinants of Acute Mountain Sickness in Mount Kinabalu, Malaysia.

Authors:  Su Lan Yang; Nor At'fina Ibrahim; Grazele Jenarun; Houng Bang Liew
Journal:  High Alt Med Biol       Date:  2020-06-30       Impact factor: 1.981

Review 4.  Pathophysiology and Therapy of High-Altitude Sickness: Practical Approach in Emergency and Critical Care.

Authors:  Gabriele Savioli; Iride Francesca Ceresa; Giulia Gori; Federica Fumoso; Nicole Gri; Valentina Floris; Angelica Varesi; Ermelinda Martuscelli; Sara Marchisio; Yaroslava Longhitano; Giovanni Ricevuti; Ciro Esposito; Guido Caironi; Guido Giardini; Christian Zanza
Journal:  J Clin Med       Date:  2022-07-06       Impact factor: 4.964

5.  Acute mountain sickness among tourists visiting the high-altitude city of Lhasa at 3658 m above sea level: a cross-sectional study.

Authors:  Per Nafstad; Hein Stigum; Tianyi Wu; Øyvind Drejer Haldorsen; Kristoffer Ommundsen; Espen Bjertness
Journal:  Arch Public Health       Date:  2016-06-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.